NCT00397228View on ClinicalTrials.gov

ALTROPANE® SPECT Imaging in Patients With Parkinson Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions
Parkinson Disease
Interventions
DRUG

ALTROPANE®

ALTROPANE® SPECT imaging

Trial Locations (1)

06510

Molecular NeuroImaging, New Haven

Sponsors
All Listed Sponsors
collaborator

Institute for Neurodegenerative Disorders

OTHER

lead

Molecular NeuroImaging

OTHER

NCT00397228 - ALTROPANE® SPECT Imaging in Patients With Parkinson Disease | Biotech Hunter | Biotech Hunter